Related Experiment Video
Updated: Aug 13, 2026
The Fastest Western in Town: A Contemporary Twist on the Classic Western Blot Analysis
Published on: February 6, 2014
Performance characteristics of a rapid western blot assay system for antibody to human immunodeficiency virus type 1
O Agbede1, S Wahab, D L Schutt
1Department of Pathology, University of Texas Medical Branch, Galveston 77550.
Insights
The WesPage system accurately detects human immunodeficiency virus type 1 (HIV-1) antibodies, matching reference laboratory results. This HIV test offers faster results and improved safety for clinical diagnostics.
Area of Science:
- Immunology
- Virology
- Clinical Diagnostics
Background:
- Enzyme immunoassay (EIA) is widely used for human immunodeficiency virus type 1 (HIV-1) antibody screening.
- Confirmatory testing is essential for accurate HIV-1 diagnosis.
- Evaluating novel diagnostic systems is crucial for improving HIV-1 detection.
Purpose of the Study:
- To compare the performance of the WesPage system against the established Western blot method for HIV-1 antibody detection.
- To assess the accuracy and reliability of the WesPage system using Food and Drug Administration criteria.
Main Methods:
- One hundred and twenty reactive sera, previously tested by EIA, were analyzed using the WesPage system and a commercial reference laboratory's Western blot.
- Standardized criteria were applied to identify specific HIV-1 antigens and antibodies on immunoblots.
- Control sera (strongly reactive, weakly reactive, non-reactive) were used to validate assay performance.
Main Results:
- The WesPage system successfully identified all major HIV-1 antigen-antibody bands in strongly reactive sera.
- Weakly reactive sera showed specific antibody detection for p24 core and gp120/160 envelope antigens.
- Results from the WesPage assay demonstrated complete agreement with the reference Western blot laboratory.
Conclusions:
- The WesPage system is a reliable and accurate method for confirming HIV-1 antibodies.
- The WesPage assay offers significant advantages, including rapid turnaround time, reduced handling of infectious materials, high resolution, and reproducibility.
- This system presents a valuable alternative for HIV-1 diagnostic testing.
Abstract:
One hundred and twenty reactive sera were selected from specimens studied by enzyme immunoassay (EIA, Abbott Laboratories, Abbott Park, North Chicago, IL) for antibodies against human immunodeficiency virus (HIV-1). Using these sera, the 'WesPage' system (American Bionetics, Inc., Haywood, CA), was compared to the Western blot evaluation performed by a commercial reference laboratory (Abbott Laboratories, Abbott Park, North Chicago, IL). Using criteria established by the Food and Drug Administration, all major bands representing specific antigens of HIV-1 and their corresponding antibodies were identified on the immunoblot membrane when the strongly reactive control serum was used in the assay. The weakly reactive control serum demonstrated antibodies to the p24 core antigen and the gp120/160 envelope antigen of the virus in addition to others. The non-reactive control serum did not react with any antigen on the immunoblot sheet. All results obtained by our evaluation agreed with the reference laboratory results. The WesPage assay offers a combination of advantages which include rapid turn around time, less direct contact with potentially infectious materials, good resolution of bands and high reproducibility of results.
